In situ micro-emulsification during surfactant enhanced oil recovery: A microfluidic study.

HYPOTHESIS: It is generally believed that the improved efficiency of surfactant enhanced oil recovery (EOR) comes from ultra-low interfacial tension (IFT) between oil and surfactant solution owing to the formation of middle-phase microemulsion. However, hindered visibility in underground porous media prevents direct observation of in situ generation of middle-phase microemulsion during surfactant flooding. Thus, direct visualization of the process is vital, and could clarify its contribution to EOR. EXPERIMENTS: Micro-emulsification of a displacing fluid containing sodium 4-dodecylbenzenesulfonate and alcohol propoxy sulfate with model oil was investigated. Phase diagrams were drawn using salinity scans, and the influence of polymer on emulsification was analyzed. Micro-emulsification was monitored through in situ fluorescent tagging via 2D-microfluidics and ex situ visualization via cryo-electron microscopy and small angle X-ray scattering. Its contribution to the oil recovery factor was quantified by measuring the volume of each phase in the eluates. FINDINGS: On-chip experiments indicated that in situ micro-emulsification occurred when the prescreened surfactant solution flowed in contact with trapped oil. The aqueous phase initially invaded the residual oil, forming a low mobility microemulsion. This microemulsion was then diluted by subsequent displacing fluid, forming a new driving fluid that caused ultra-low IFT in the trapped oil downstream. Under the synergistic effect of micellar solubilization and trapped-oil mobilization, the recovery factor could be increased by up to 40% over waterflooding and 43% on polymer inclusion in the formulation.

CO2-Triggered ON/OFF Wettability Switching on Bioinspired Polylactic Acid Porous Films for Controllable Bioadhesion.

Bioinspired honeycomb-like porous films with switchable properties have drawn much attention recently owing to their potential application in scenarios in which the conversion between two opposite properties is required. Herein, the CO2-gas-triggered ON/OFF switching wettability of biocompatible polylactic acid (PLA) honeycomb porous films is fabricated. Highly ordered porous films with diameters between 2.0 and 2.8 µm are separately prepared from complexes of nonresponsive PLA and a CO2-sensitive melamine derivative [N2,N4,N6-tris(3-(dimethylamino)propyl)-1,3,5-triazine-2,4,6-triamine, MET] via the breath figure method. The hydrophilic CO2-sensitive groups can be precisely arranged in the pore's inner surface and/or top surface of the films by simply changing the PLA/MET ratio. The sensitive groups in the pore's inner surface act as a switch triggered by CO2 gas controlling water to enter the pores or not, thus resulting in ON/OFF switching wettability. The largest response of the water contact angle of honeycomb films reaches 35°, from 100 to 65°, leading to an obvious hydrophobic-hydrophilic conversion. The improved surface wettability enhances the interaction between the cell and honeycomb film surface, thus resulting in a better cell attachment. Such smart properties accompanying the biocompatible polymer and biological gas trigger facilitate possible biomedical and bioengineering applications in the future for these films.

Direct formation of hydrophilic honeycomb film by self-assembly in breath figure templating of hydrophobic polylacticacid/ionic surfactant complexes.

Honeycomb-patterned porous films with good surface wettability have great potential applications in various areas. However, hydrophilic honeycomb films are difficult to obtain using the direct self-assembly of pure (co)polymers. Thus, additional and special treatments are required to improve film wettability, which makes the procedure complicated and difficult to access. In this study, a facile way to prepare hydrophilic honeycomb-structured porous films is proposed that uses the direct self-assembly of complexes of biocompatible hydrophobic poly(l-lactic acid) and dodecyltrimethylammonium chloride by breath figure templating. The addition of ionic surfactant not only improves film quality but also confers good wettability. The obtained hydrophilic pore arrays were found to effectively promote cell attachment. Such a hydrophilic honeycomb-patterned porous film could find potential applications where pore wetting is required, including tissue engineering, lithography, and nanoparticle embedding.

Acid-activatable prodrug nanogels for efficient intracellular doxorubicin release.

Endosomal pH-activatable doxorubicin (DOX) prodrug nanogels were designed, prepared, and investigated for triggered intracellular drug release in cancer cells. DOX prodrugs with drug grafting contents of 3.9, 5.7, and 11.7 wt % (denoted as prodrugs 1, 2, and 3, respectively) were conveniently obtained by sequential treatment of poly(ethylene glycol)-b-poly(2-hydroxyethyl methacrylate-co-ethyl glycinate methacrylamide) (PEG-b-P(HEMA-co-EGMA)) copolymers with hydrazine and doxorubicin hydrochloride. Notably, prodrugs 1, 2, and 3 formed monodispersed nanogels with average sizes of 114.4, 75.3, and 66.3 nm, respectively, in phosphate buffer (PB, 10 mM, pH 7.4). The in vitro release results showed that DOX was released rapidly and nearly quantitatively from DOX prodrug nanogels at endosomal pH and 37 °C in 48 h, whereas only a minor amount (ca. 20% or less) of drug was released at pH 7.4 under otherwise the same conditions. Confocal laser scanning microscope (CLSM) observations revealed that DOX prodrug nanogels delivered and released DOX into the cytosols as well as cell nuclei of RAW 264.7 cells following 24 h incubation. MTT assays demonstrated that prodrug 3 had pronounced cytotoxic effects to tumor cells following 72 h incubation with IC(50) data determined to be 2.0 and 3.4 µg DOX equiv/mL for RAW 264.7 and MCF-7 tumor cells, respectively. The corresponding polymer carrier, PEG-b-P(HEMA-co-GMA-hydrazide), was shown to be nontoxic up to a tested concentration of 1.32 mg/mL. These endosomal pH-activatable DOX prodrug nanogels uniquely combining features of water-soluble macromolecular prodrugs and nanogels offer a promising platform for targeted cancer therapy.